Decreased interleukin-10 production by neonatal monocytes and T cells: Relationship to decreased production and expression of tumor necrosis factor-alpha and its receptors

被引:71
作者
Chheda, S
Palkowetz, KH
Garofalo, R
Rassin, DK
Goldman, AS
机构
[1] University of Texas Medical Branch, Department of Pediatrics, Galveston
[2] Division of Neonatology, Department of Pediatrics, University of Texas Medical Branch, Galveston, TX 77555-0526
关键词
D O I
10.1203/00006450-199609000-00018
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The production of IL-10 by human neonatal blood mononuclear leukocytes (BML) stimulated with lipopolysaccharide (LPS), tumor necrosis factor-alpha (TNF-alpha), antibodies to CD3, or phorbol 12-myristate 13-acetate (PMA) was measured. The production of IL-10 by neonatal BML cultured with LPS or TNF-alpha was similar to 20 and similar to 15%, respectively, of adult BML. The combination of human recombinant TNF-alpha and LPS failed to augment IL-10 production in neonatal BML. The decreased production of IL-10 by neonatal leukocytes was not due to an autocrine feedback mechanism because only low concentrations of IL-10 were found in newborn sera. A connection with TNF-alpha could not be ruled out, because TNF-alpha production by LPS-stimulated newborn BML and the expression of TNF-alpha receptors on newborn monocytes were reduced. Mean +/- SD of concentrations of IL-10 in supernatants from adult and neonatal BML after stimulation with antibodies to human CD3 for 48 or 72 h were 914 +/- 386 and 178 +/- 176 pg/mL, respectively (p < 0.0001). Ln experiments with enriched populations of neonatal T cells, the addition of PMA failed to augment IL-10 production. This suggested that newborn T cells may be in a different state of activation than adult T cells Thus, IL-10 production in neonatal monocytes and T cells is reduced and this study suggests that the reduction may be secondary in part to regulatory processes involving TNF-alpha and its receptors.
引用
收藏
页码:475 / 483
页数:9
相关论文
共 61 条
[1]   DEVELOPMENT OF THE HUMAN-ANTIBODY REPERTOIRE [J].
ADDERSON, EE ;
JOHNSTON, JM ;
SHACKELFORD, PG ;
CARROLL, WL .
PEDIATRIC RESEARCH, 1992, 32 (03) :257-263
[2]  
AERDE JEE, 1991, NEONATAL NUTR METABO, P467
[3]  
AGOSTINI C, 1995, J IMMUNOL, V154, P2928
[4]  
ARMITAGE RJ, 1993, J IMMUNOL, V150, P3671
[5]   INCREASED LEVELS OF SOLUBLE TUMOR-NECROSIS-FACTOR-ALPHA RECEPTORS IN SERUM FROM PREGNANT-WOMEN AND IN SERUM AND URINE SAMPLES FROM NEWBORNS [J].
AUSTGULEN, R ;
LIABAKK, NB ;
LIEN, E ;
ESPEVIK, T .
PEDIATRIC RESEARCH, 1993, 33 (01) :82-86
[6]  
AUSTGULEN R, 1993, OBSTET GYNECOL, V82, P343
[7]  
BOFILL M, 1994, J IMMUNOL, V152, P5613
[8]  
BRIERE F, 1993, NOUV REV FR HEMATOL, V35, P233
[9]   IDENTIFICATION OF 2 TYPES OF TUMOR-NECROSIS-FACTOR RECEPTORS ON HUMAN CELL-LINES BY MONOCLONAL-ANTIBODIES [J].
BROCKHAUS, M ;
SCHOENFELD, HJ ;
SCHLAEGER, EJ ;
HUNZIKER, W ;
LESSLAUER, W ;
LOETSCHER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (08) :3127-3131
[10]   A NOVEL X-LINKED COMBINED IMMUNODEFICIENCY DISEASE [J].
BROOKS, EG ;
SCHMALSTIEG, FC ;
WIRT, DP ;
ROSENBLATT, HM ;
ADKINS, LT ;
LOOKINGBILL, DP ;
RUDLOFF, HE ;
RAKUSAN, TA ;
GOLDMAN, AS .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (05) :1623-1631